Silver Oak Advisory Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Silver Oak Advisory Group’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Sell	682 -44	-6%	-$12.5K	0.08%	86
2026 Q1	$202K	Hold	726	–	–	0.09%	78
2025 Q4	$219K	Hold	726	–	–	0.1%	71
2025 Q3	$203K	Buy	+726	New	+$198K	0.09%	77
2025 Q1	–	Sell	-770	Closed	-$252K	–	66
2024 Q4	$252K	Sell	770 -7	-0.9%	-$2.38K	0.13%	53
2024 Q3	$259K	Hold	777	–	–	0.13%	56
2024 Q2	$212K	Hold	777	–	–	0.12%	61
2024 Q1	$269K	Hold	777	–	–	0.15%	56
2023 Q4	$251K	Sell	777 -120	-13%	-$37.6K	0.15%	55
2023 Q3	$321K	Hold	897	–	–	0.21%	44
2023 Q2	$340K	Hold	897	–	–	0.22%	39
2023 Q1	$429K	Buy	+897	New	+$420K	0.29%	32

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Silver Oak Advisory Group's BIO Position: Q2 2026 in Review

Silver Oak Advisory Group reduced its Bio-Rad Laboratories Class A (BIO) stake by 6.1% in Q2 2026, selling an estimated $12.5K and leaving 682 shares worth $200K. The position accounts for 0.08% of the portfolio, ranked #86.

Silver Oak Advisory Group first reported a position in BIO in Q1 2023 and has held it in 12 quarters since. The position peaked at $429K in Q1 2023. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Silver Oak Advisory Group held 682 shares of Bio-Rad Laboratories Class A worth $200K as of Q2 2026.
Silver Oak Advisory Group sold 44 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $12.5K.
Bio-Rad Laboratories Class A made up 0.08% of Silver Oak Advisory Group's portfolio in Q2 2026, its #86 holding.
Silver Oak Advisory Group first reported a position in Bio-Rad Laboratories Class A in Q1 2023 and has held it in 12 quarters since.
Silver Oak Advisory Group's Bio-Rad Laboratories Class A position peaked at $429K in Q1 2023.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Silver Oak Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.